Any of the adverse reactions listed below may occur. Therefore, patients receiving this drug treatment should be carefully monitored, and if any abnormalities are noted, appropriate measures should be taken including discontinuation of this drug treatment.
|
|
0.1% to <5% |
Frequency unknown |
| Gastrointestinal | Abdominal distension, diarrhea, abdominal discomfort, inappetence, thirst | Nausea, constipation, abdominal pain, vomiting, eructation, heartburn, etc. |
| Renal | Increased BUN, increased blood creatinine, etc. | |
| Metabolic | Increased blood ammonia, etc. | |
| Hepatic | Increased AST, increased ALT, increased T-Bil, etc. | |
| Dermatological | Rash, pruritus, etc. | |
| Others | Malaise, edema (face, lower limb, etc.), redness, hot flush |
| Reporting of suspected adverse drug reactions |
| Please contact: |
| HI-Eisai Pharmaceutical, Inc. |
| +63 2 88875837 / +63 2 88875160 / +63 9088672236 |
| Or Report to FDA Philippines: www.fda.gov.ph |
